Company Filing History:
Years Active: 2006
Title: The Innovations of Markus Grütter
Introduction
Markus Grütter is a notable inventor based in Hochwald, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the study of proteases. His work has implications for drug design and therapeutic applications.
Latest Patents
One of Markus Grütter's key patents is related to the crystal structure of cysteine protease. This invention pertains to the death protease CPP32 in its crystallized form and outlines a method for its preparation. The patent also provides a three-dimensional model of CPP32, which enhances the design of CPP32 modulators.
Career Highlights
Markus Grütter is associated with Novartis International AG, a leading global healthcare company. His role at Novartis has allowed him to work on groundbreaking research and development projects that aim to improve health outcomes.
Collaborations
Throughout his career, Markus has collaborated with esteemed colleagues such as Peer Mittl and Stefania Di Marco. These collaborations have fostered innovation and have contributed to the advancement of their shared research goals.
Conclusion
Markus Grütter's work exemplifies the intersection of innovation and practical application in the field of biochemistry. His contributions, particularly in the area of cysteine protease, highlight the importance of research in developing new therapeutic strategies.